Evidence map›Paper›PMID 40413164›Full record

ArticleNature communications2025

Alveolar epithelial and vascular CXCR2 mediates transcytosis of CXCL1 in inflamed lungs.

Katharina Thomas, Jan Rossaint, Nadine Ludwig, Sina Mersmann, Niklas Kötting, Julia Grenzheuser, Lena Schemmelmann, Marina Oguama, Andreas Margraf, Helena Block and 13 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Targeting CXCR1/2 suppresses TThe journal of allergy and clinical immunology. Global · 2026
    Article
  5. Article
  6. Alveolar macrophage-neutrophil crosstalk in acute lung injury: mechanisms, feedback loops, and therapeutic opportunities.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Katharina Thomas *Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
Jan Rossaint *Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
Nadine LudwigDepartment of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
Sina MersmannDepartment of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
Niklas KöttingDepartment of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
Julia GrenzheuserDepartment of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
Lena SchemmelmannDepartment of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
Marina OguamaDepartment of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.ORCID http://orcid.org/0000-0001-5899-5045
Andreas MargrafDepartment of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
Helena BlockDepartment of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
Katharina HenkeDepartment of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
Katharina HellenthalDepartment of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.ORCID http://orcid.org/0000-0002-5366-9627
Valbona MirakajDepartment of Anaesthesiology and Intensive Care Medicine, University Tübingen, Tübingen, Germany.
Volker GerkeInstitute of Medical Biochemistry, Centre for Molecular Biology of Inflammation (ZMBE), University of Münster, Münster, Germany.ORCID http://orcid.org/0000-0001-7208-8206
Uwe HansenInstitute of Experimental Musculoskeletal Medicine, University Hospital Münster, Münster, Germany.
Karin GäherInstitute of Experimental Musculoskeletal Medicine, University Hospital Münster, Münster, Germany.
Miguel EngelhardtInstitute of Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany.
Johannes RothInstitute of Immunology, University Hospital Münster, Münster, Germany.ORCID http://orcid.org/0000-0001-7035-8348
Johannes EbleInstitute of Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany.
Elin HubCentre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Antal RotCentre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Ronen AlonDepartment of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0001-9161-6369
Alexander ZarbockDepartment of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany. zarbock@uni-muenster.de.ORCID http://orcid.org/0000-0002-2124-1714

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) CO2096/2-1Deutsche Forschungsgemeinschaft (German Research Foundation) INST211/1073-1Deutsche Forschungsgemeinschaft (German Research Foundation) INST211/604-3Deutsche Forschungsgemeinschaft (German Research Foundation) INST 211/984-1Deutsche Forschungsgemeinschaft (German Research Foundation) RO 4537/4-2Deutsche Forschungsgemeinschaft (German Research Foundation) RO 4537/5-2Deutsche Forschungsgemeinschaft (German Research Foundation) ZA428/14-2Deutsche Forschungsgemeinschaft (German Research Foundation) ZA428/18-2German-Israeli Foundation for Scientific Research and Development (GIF) I-1470-412.13/2018Wellcome Trust (Wellcome) 200817/Z/16/Z
6 · The paper itself

Abstract

Pulmonary infections are characterized by neutrophil recruitment into the lung driven by chemokine ligands of CXCR2, which is expressed on neutrophils, but also present in non-hematopoietic lung cells, in which its role remains unclear. We hypothesize that CXCR2 in epithelial and endothelial cells contributes to neutrophil recruitment into the lung by modifying the availability of its cognate chemokines in lung alveoli. Using conditional endothelial and epithelial CXCR2 knockout mice, we demonstrate that selective CXCR2 deletion in either compartment impairs neutrophil recruitment into the lung during bacterial pneumonia and reduces bacterial clearance. We show that CXCR2 ablation in epithelial and endothelial cells compromises respective trans-epithelial and trans-endothelial transcytosis of alveolar CXCL1. Mechanistically, CXCR2-mediated CXCL1 endothelial and epithelial cell transcytosis requires the function of Bruton's tyrosine kinase in these cells. In conclusion, CXCR2 plays an important role in alveolar epithelial and endothelial cells, where it mediates cognate chemokine transcytosis, thus actively supporting their activities in neutrophil recruitment to the infected lungs.

Indexed as

Alveolar Epithelial CellsChemokine CXCL1Pneumonia, BacterialPulmonary AlveoliReceptors, Interleukin-8BTranscytosisAnimalsEndothelial CellsEpithelial CellsHumansLungMiceMice, Inbred C57BLMice, KnockoutNeutrophil InfiltrationNeutrophilsChemokine CXCL1Cxcl1 protein, mouseCxcr2 protein, mouseReceptors, Interleukin-8B

Identifiers

PMID40413164
PMCPMC12103508

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.